Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells
about
Adoptive T-cell transfer therapy and oncogene-targeted therapy for melanoma: the search for synergyTargeting and killing of glioblastoma with activated T cells armed with bispecific antibodies.Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway.Natural product and natural product derived drugs in clinical trials.Isolation of Cottonseed Extracts That Affect Human Cancer Cell Growth.
P2860
Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells
@ast
Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells
@en
Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells
@nl
type
label
Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells
@ast
Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells
@en
Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells
@nl
prefLabel
Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells
@ast
Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells
@en
Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells
@nl
P2093
P2860
P1433
P1476
Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells
@en
P2093
Archana Thakur
Dana Schalk
Fazlul H Sarkar
Lawrence G Lum
Ramzi Mohommad
Sanjeev Banerjee
P2860
P304
P356
10.1371/JOURNAL.PONE.0047520
P407
P577
2012-01-01T00:00:00Z